Molecular therapeutics of pancreatic ductal adenocarcinoma:targeted pathways and the role of cancer stem cells

Molecular therapeutics of pancreatic ductal adenocarcinoma:targeted pathways and the role of cancer stem cells

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers in humans due to late detection and highly metastatic characteristics. PDAC cells vary in their tumorigenic capabilities with the presence of a subset of PDAC cells known as pancreatic cancer stem cells (CSCs), which are more...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Stoica, A, Chang, C-H, Pauklin, S
Format:	Journal article
Sprache:	English
Veröffentlicht:	Cell Press 2020

Ähnliche Einträge

Mechanisms of cancer cell death: Therapeutic implications for pancreatic ductal adenocarcinoma
von: Pook, H, et al.
Veröffentlicht: (2021)

In-silico identification of therapeutic targets in pancreatic ductal adenocarcinoma using WGCNA and Trader
von: Parvin Yavari, et al.
Veröffentlicht: (2024-10-01)

TRP Channels Interactome in Pancreatic Ductal Adenocarcinoma: A Potential Therapeutic Target
von: Ahmad Taha Khalaf, et al.
Veröffentlicht: (2023-03-01)

Therapeutic Status and Available Strategies in Pancreatic Ductal Adenocarcinoma
von: Gitika Thakur, et al.
Veröffentlicht: (2021-02-01)

Hydrogel-Based Therapeutics for Pancreatic Ductal Adenocarcinoma Treatment
von: Jinlu Liu, et al.
Veröffentlicht: (2023-10-01)

Identifying the mechanisms driving pancreatic ductal adenocarcinoma stem cell characteristics using single-cell RNA-sequencing
von: Stoica, AF
Veröffentlicht: (2023)

BRD9-SMAD2/3 orchestrates stemness and tumorigenesis in pancreatic ductal adenocarcinoma
von: Feng, Y, et al.
Veröffentlicht: (2023)

Molecular characteristics of early‐onset pancreatic ductal adenocarcinoma
von: Silvana Debernardi, et al.
Veröffentlicht: (2024-03-01)

Pancreatic Ductal Adenocarcinoma: Molecular Pathology and Predictive Biomarkers
von: Mehran Taherian, et al.
Veröffentlicht: (2022-09-01)

Identification of GRIN2D as a novel therapeutic target in pancreatic ductal adenocarcinoma
von: Jiatong Wang, et al.
Veröffentlicht: (2023-08-01)

The Emergence of TRP Channels Interactome as a Potential Therapeutic Target in Pancreatic Ductal Adenocarcinoma
von: Yuanyuan Wei, et al.
Veröffentlicht: (2023-04-01)

Identification and validation of stemness-based and ferroptosis-related molecular clusters in pancreatic ductal adenocarcinoma
von: Shiye Ruan, et al.
Veröffentlicht: (2024-03-01)

Kinase activities in pancreatic ductal adenocarcinoma with prognostic and therapeutic avenues
von: Andrea Vallés‐Martí, et al.
Veröffentlicht: (2024-08-01)

Metabolic signatures in pancreatic ductal adenocarcinoma: diagnostic and therapeutic implications
von: Ruining Gong, et al.
Veröffentlicht: (2023-12-01)

THE SUBTYPES OF PANCREATIC DUCTAL ADENOCARCINOMAS
von: Apeksha Kakkar, et al.
Veröffentlicht: (2016-12-01)

Syndecans and Pancreatic Ductal Adenocarcinoma
von: Nausika Betriu, et al.
Veröffentlicht: (2021-02-01)

Dysregulation of miRNAs Targeting the IGF-1R Pathway in Pancreatic Ductal Adenocarcinoma
von: Maria Dobre, et al.
Veröffentlicht: (2021-07-01)

The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma
von: Wang, L, et al.
Veröffentlicht: (2015)

Role of Endoscopic Ultrasound in Diagnosis of Pancreatic Ductal Adenocarcinoma
von: Abhirup Chatterjee, et al.
Veröffentlicht: (2023-12-01)

The Emerging Role of Microbiota and Microbiome in Pancreatic Ductal Adenocarcinoma
von: Sona Ciernikova, et al.
Veröffentlicht: (2020-12-01)

Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical study
von: Heng‐Chung Kung, et al.
Veröffentlicht: (2023-04-01)

Realising the therapeutic potential of the human microbiota in metastatic pancreatic ductal adenocarcinoma
von: James M. Halle-Smith, et al.
Veröffentlicht: (2023-12-01)

Nanoparticle-Based Therapeutic Strategies for Enhanced Pancreatic Ductal Adenocarcinoma Immunotherapy
von: Wanting Hou, et al.
Veröffentlicht: (2022-09-01)

The T cell architecture of pancreatic ductal adenocarcinoma
von: Sivakumar, S, et al.
Veröffentlicht: (2019)

The T-cell architecture of pancreatic ductal adenocarcinoma
von: Sivakumar, S, et al.
Veröffentlicht: (2019)

Ubiquitin signaling in pancreatic ductal adenocarcinoma
von: Shengnan Lv, et al.
Veröffentlicht: (2023-12-01)

Dual drug-loaded tumor-targeted polymeric nanoparticles for enhancing therapeutic response in pancreatic ductal adenocarcinoma
von: Naga Malleswara Rao Nakka, et al.
Veröffentlicht: (2024-10-01)

Genome-wide CRISPR screens identify PKMYT1 as a therapeutic target in pancreatic ductal adenocarcinoma
von: Simin Wang, et al.
Veröffentlicht: (2024-04-01)

Role of the TRP Channels in Pancreatic Ductal Adenocarcinoma Development and Progression
von: Gonçalo Mesquita, et al.
Veröffentlicht: (2021-04-01)

Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma.
von: Ole Helm, et al.
Veröffentlicht: (2014-01-01)

Diagnostic and therapeutic recommendations in pancreatic ductal adenocarcinoma. Recommendations of the Working Group of the Polish Pancreatic Club
von: Katarzyna Winter, et al.
Veröffentlicht: (2019-03-01)

Pancreatic ductal adenocarcinoma: the latest on diagnosis, molecular profiling, and systemic treatments
von: Doaa Bugazia, et al.
Veröffentlicht: (2024-07-01)

Epigenetic Landscape of DNA Methylation in Pancreatic Ductal Adenocarcinoma
von: Peiyi Liu, et al.
Veröffentlicht: (2024-11-01)

Development of gemcitabine-modified miRNA mimics as cancer therapeutics for pancreatic ductal adenocarcinoma
von: John G. Yuen, et al.
Veröffentlicht: (2024-03-01)

Gene Therapy Using Nanocarriers for Pancreatic Ductal Adenocarcinoma: Applications and Challenges in Cancer Therapeutics
von: Eun-Jeong Won, et al.
Veröffentlicht: (2022-01-01)

The Use of Personalized Medicine in Pancreatic Ductal Adenocarcinoma (PDAC): New Therapeutic Opportunities
von: Inês Mendes, et al.
Veröffentlicht: (2024-12-01)

A Bitter Taste Receptor as a Novel Molecular Target on Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma
von: Jessica Hung, et al.
Veröffentlicht: (2023-03-01)

SAMD1 suppresses epithelial-mesenchymal transition pathways in pancreatic ductal adenocarcinoma.
von: Clara Simon, et al.
Veröffentlicht: (2024-08-01)

Imaging p53 in pancreatic ductal adenocarcinoma
von: Koustoulidou, S
Veröffentlicht: (2017)

PKM2 is not required for pancreatic ductal adenocarcinoma
von: Danai, Laura V, et al.
Veröffentlicht: (2018)